Cue Biopharma Inc
(CUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,321 | 51,614 | 29,726 | 66,126 | 67,927 |
| Marketable Securities | 9,878 | 24,675 | 29,457 | N/A | N/A |
| Receivables | 196 | 57 | 796 | 736 | 6,052 |
| TOTAL | $68,755 | $77,187 | $61,700 | $69,004 | $75,947 |
| Non-Current Assets | |||||
| PPE Net | 1,325 | 1,499 | 1,642 | 1,765 | 1,918 |
| Other Non-Current Assets | 11,602 | 12,597 | 12,958 | 13,980 | 12,839 |
| TOTAL | $12,927 | $14,096 | $14,600 | $15,745 | $14,757 |
| Total Assets | $81,682 | $91,283 | $76,300 | $84,749 | $90,704 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,963 | 1,963 | 963 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,151 | 2,731 | 2,045 | 1,568 | 2,617 |
| Accrued Expenses | 2,843 | 3,554 | 3,879 | 3,559 | 3,406 |
| Other current liabilities | 2,521 | N/A | N/A | N/A | N/A |
| TOTAL | $13,810 | $11,548 | $10,222 | $8,323 | $11,411 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,077 | 8,035 | 8,993 | 9,913 | 9,861 |
| Other Non-Current Liabilities | 5,778 | 6,018 | 6,321 | 6,757 | 4,759 |
| TOTAL | $12,855 | $14,053 | $15,314 | $16,670 | $14,620 |
| Total Liabilities | $26,665 | $25,601 | $25,536 | $24,993 | $26,031 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,178 | 43,168 | 35,386 | 35,382 | 35,372 |
| Common Shares | 43 | 43 | 35 | 35 | 34 |
| Retained earnings | -263,565 | -250,457 | -235,864 | -224,909 | -211,701 |
| Other shareholders' equity | -39 | -96 | -92 | 0 | 0 |
| TOTAL | $55,017 | $65,682 | $50,764 | $59,756 | $64,673 |
| Total Liabilities And Equity | $81,682 | $91,283 | $76,300 | $84,749 | $90,704 |